| TRAW Shares Outstanding History Table | ||||||||||||||||||||||||||
Below is a table of the TRAW shares outstanding history going back to 5/1/2024:
Also see: TRAW Market Cap History TRAW YTD Return |
As of 8/12/2026 Traws Pharma has 15.37 million TRAW shares outstanding. Investors often track the TRAW shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows TRAW share count trends over time, with 12 historical shares outstanding datapoints presented, dating back to 5/1/2024.

| TRAW Shares Outstanding History Table | ||||||||||||||||||||||||||
Below is a table of the TRAW shares outstanding history going back to 5/1/2024:
Also see: TRAW Market Cap History TRAW YTD Return |
| TRAW Shares Outstanding History Chart | |||||||||||||||||||||||||||
TRAW Historical Shares Outstanding: +229.36% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||
| TRAW Stock Price Chart |
| About Traws Pharma Inc |
| Traws Pharma, Inc., formerly Onconova Therapeutics, Inc., is a virology and oncology company. Co. is engaged in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Its proprietary portfolio includes, TRX100 (viroksavir), TRX01 (travaltrevir), and Narazaciclib. Viroksavir is a cap-dependent endonuclease inhibitor for influenza. Travaltrevir is a Mpro protease inhibitor for COVID19. Narazaciclib is a cyclin-dependent kinases (CDK) 4/6 inhibitor for low-grade endometrioid endometrial cancer (LGEEC). We show 12 historical shares outstanding datapoints in our coverage of TRAW's shares outstanding history. Understanding the changing numbers of TRAW shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like TRAW versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching TRAW by allowing them to research TRAW shares outstanding history as well as any other stock in our coverage universe. |
| TRAW Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| TRAW Share Performance |
| Shares Outstanding Peers |
| Traws Pharma (TRAW) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
TRDA Shares Outstanding History TRLV Shares Outstanding History TRML Shares Outstanding History TROV Shares Outstanding History TRVI Shares Outstanding History TRVN Shares Outstanding History TSBX Shares Outstanding History TSHA Shares Outstanding History TSRO Shares Outstanding History TSVT Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.